Sign in

CIK 0001650664

  • Non-accelerated filer
  • Smaller reporting company

Editas Medicine, Inc.

Sign in to watch
Ticker
EDIT
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
464097528
Phone
+1 617-401-9000
Business address
11 HURLEY ST., CAMBRIDGE, MA, 02141
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Open-market sale EVP, CHIEF BUSINESS OFFICER sold 1,123 shares at $11.54 ($12,956)
  5. 4 Open-market sale EVP, CHIEF FINANCIAL OFFICER sold 1,527 shares at $11.54 ($17,617)
  6. 4 Grant or award CEO acquired 86,655 shares (grant or award)
  7. 3 Insider Initial Statement of Ownership
  8. 4 Open-market sale EVP, CHIEF BUSINESS OFFICER sold 297 shares at $13.11 ($3,895)
  9. 4 Derivatives Options or other derivatives
  10. 4 Open-market sale EVP, CHIEF BUSINESS OFFICER sold 1,545 shares at an average $26.61 ($41,115)
  11. 4 Open-market sale EVP, CHIEF BUSINESS OFFICER sold 403 shares at $17.33 ($6,983)
  12. 4 Open-market sale EVP, CHIEF FINANCIAL OFFICER sold 767 shares at $17.33 ($13,290)
  13. 4 Grant or award EVP, CHIEF BUSINESS OFFICER acquired 37,593 shares (grant or award)
  14. 4 Grant or award EVP, CHIEF SCIENTIFIC OFFICER acquired 31,709 shares (grant or award)
  15. 4 Grant or award CHIEF FINANCIAL OFFICER acquired 53,499 shares (grant or award)
  16. 4 Open-market sale EVP, CHIEF BUSINESS OFFICER sold 302 shares at $17.63 ($5,323)
  17. 4 Open-market sale Chief Financial Officer sold 1,744 shares at $25.70 ($44,821)
  18. 4 Open-market sale CEO sold 18,252 shares at $26.95 ($491,979)
  19. 4 Grant or award EVP, Chief Business Officer acquired 3,472 shares (grant or award)
  20. 4 Grant or award EVP/Chief Medical Officer acquired 4,243 shares (grant or award)

Page 7 of 18 · 351 filings